CQ Magazine | Much Ado about Vaping

Marc Scheineson comments on the growing calls for Congress and the U.S. Food and Drug Administration to regulate the e-cigarette industry.

Marc Scheineson is quoted on the cases that may historically alter the scope of authority for the Food and Drug Administration and the Centers for Medicare & Medicaid Services.

Marc Scheineson comments on the U.S. Food and Drug Administration’s approach to vape shops that make, stock, and sell illicit goods.

Marc Scheineson is quoted on the timing for getting the Food and Drug Administration’s user fee reauthorization package to President Biden’s desk before Congress leaves for summer recess.

Alston & Bird has expanded its health care and life sciences regulatory and compliance capabilities with the addition of counsel Alexandra Marzelli, former associate chief counsel at the U.S. Food and Drug Administration (FDA). Based in the firm’s Washington, D.C. office, Marzelli joins Alston & Bird’s Health Care and FDA/Food, Drug & Device Groups, where she will advise clients on the FDA’s complex approval process and regulatory compliance for prescription and over-the-counter drugs, biologics, medical devices, food ingredients, and other products regulated by the agency.